Assertio Holdings, Inc.
US ˙ NasdaqCM ˙ US04546C2052

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Timothy P Walbert. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Timothy P Walbert har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:MIRM / Mirum Pharmaceuticals, Inc. Director 5.703
US:BMRN / BioMarin Pharmaceutical Inc. Director 9.780
US:SGMT / Sagimet Biosciences Inc. Director 2.200
US:HZNP / Horizon Therapeutics Plc Chairman, President and CEO, Director 0
US:AUPH / Aurinia Pharmaceuticals Inc. Director 14.612
US:XCUR / Exicure, Inc. Director 50.000
US:ASRT / Assertio Holdings, Inc. Director 211.111
US:ZCOR / Zyla Life Sciences Director 0
US:SCMP / Sucampo Pharmaceuticals, Inc. Director 0
US:XOMA / XOMA Royalty Corporation Director 8.000
US:RPTP / Raptor Pharmaceutical Corp. Director 52.918
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Timothy P Walbert. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb ASRT / Assertio Holdings, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ASRT / Assertio Holdings, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ASRT / Assertio Holdings, Inc. Insider Trades
Insidersalg ASRT / Assertio Holdings, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ASRT / Assertio Holdings, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ASRT / Assertio Holdings, Inc. Insider Trades
Insiderkøb AUPH / Aurinia Pharmaceuticals Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ASRT / Assertio Holdings, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AUPH / Aurinia Pharmaceuticals Inc. Insider Trades
Insidersalg AUPH / Aurinia Pharmaceuticals Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ASRT / Assertio Holdings, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AUPH / Aurinia Pharmaceuticals Inc. Insider Trades
Insiderkøb MIRM / Mirum Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ASRT / Assertio Holdings, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MIRM / Mirum Pharmaceuticals, Inc. Insider Trades
Insidersalg MIRM / Mirum Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ASRT / Assertio Holdings, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MIRM / Mirum Pharmaceuticals, Inc. Insider Trades
Insiderkøb SGMT / Sagimet Biosciences Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ASRT / Assertio Holdings, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SGMT / Sagimet Biosciences Inc. Insider Trades
Insidersalg SGMT / Sagimet Biosciences Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ASRT / Assertio Holdings, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SGMT / Sagimet Biosciences Inc. Insider Trades
Insiderkøb XCUR / Exicure, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ASRT / Assertio Holdings, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

XCUR / Exicure, Inc. Insider Trades
Insidersalg XCUR / Exicure, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ASRT / Assertio Holdings, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

XCUR / Exicure, Inc. Insider Trades
Insiderkøb XOMAO / XOMA Royalty Corporation - Preferred Stock – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ASRT / Assertio Holdings, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

XOMAO / XOMA Royalty Corporation - Preferred Stock Insider Trades
Insidersalg XOMAO / XOMA Royalty Corporation - Preferred Stock – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ASRT / Assertio Holdings, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

XOMAO / XOMA Royalty Corporation - Preferred Stock Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Timothy P Walbert som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-06-02 2025-05-29 4 MIRM Mirum Pharmaceuticals, Inc.
Common Stock
M - Exercise 5.703 5.703
2025-05-22 2025-05-20 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 6.650 9.780 212,46
2025-03-07 3/A BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
416
2025-02-26 2025-02-24 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 3.130 3.130
2024-04-03 3 SGMT Sagimet Biosciences Inc.
Series A Common Stock
2.200
2023-10-06 2023-10-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
D - Sale to Issuer -49.935 0 -100,00 116,50 -5.817.428
2023-10-06 2023-10-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
D - Sale to Issuer -100.300 0 -100,00 116,50 -11.684.950
2023-10-06 2023-10-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
D - Sale to Issuer -107.739 0 -100,00 116,50 -12.551.594
2023-10-06 2023-10-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
D - Sale to Issuer -616.772 0 -100,00 116,50 -71.853.938
2023-01-06 2023-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -97.461 616.493 -13,65 113,24 -11.036.484 69.811.667
2023-01-06 2023-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 219.995 713.954 44,54
2023-01-04 2023-01-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -46.365 493.959 -8,58 113,80 -5.276.337 56.212.534
2023-01-04 2023-01-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 104.498 540.324 23,98
2023-01-04 2022-12-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -6.729 49.656 -11,93 113,80 -765.760 5.650.853
2023-01-04 2022-12-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 15.185 56.385 36,86
2022-06-03 2022-06-03 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -9.800 435.826 -2,20 92,74 -908.852 40.418.503
2022-06-03 2022-06-03 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -15.200 445.626 -3,30 92,08 -1.399.616 41.033.242
2022-06-03 2022-06-03 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 25.000 460.826 5,74 22,14 553.500 10.202.688
2022-06-02 2022-05-31 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -2.700 435.549 -0,62 94,46 -255.042 41.141.959
2022-06-02 2022-05-31 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -3.800 438.249 -0,86 93,21 -354.198 40.849.189
2022-06-02 2022-05-31 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -18.500 442.049 -4,02 92,04 -1.702.740 40.686.190
2022-05-20 2022-05-18 4 AUPH Aurinia Pharmaceuticals Inc.
Stock Option (right to buy)
A - Award 14.612 14.612
2022-05-20 2022-05-18 4 AUPH Aurinia Pharmaceuticals Inc.
Restricted Stock Unit
A - Award 8.733 8.733
2022-05-20 2022-05-20 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -25.000 767.565 -3,15
2022-05-20 2022-05-20 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -25.000 460.549 -5,15 90,00 -2.250.000 41.449.410
2022-05-20 2022-05-20 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 25.000 485.549 5,43 22,14 553.500 10.750.055
2022-05-13 2022-05-11 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -17.600 792.565 -2,17
2022-05-13 2022-05-11 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -17.600 460.549 -3,68 90,00 -1.584.000 41.449.410
2022-05-13 2022-05-11 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 17.600 478.149 3,82 22,14 389.664 10.586.219
2022-05-10 2022-05-06 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -7.400 810.165 -0,91
2022-05-10 2022-05-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -5.000 460.549 -1,07 91,11 -455.550 41.960.619
2022-05-10 2022-05-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -2.400 465.549 -0,51 90,33 -216.792 42.053.041
2022-05-10 2022-05-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 7.400 467.949 1,61 22,14 163.836 10.360.391
2022-05-04 2022-05-02 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -3.450 460.549 -0,74 97,43 -336.134 44.871.289
2022-05-04 2022-05-02 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -7.608 463.999 -1,61 96,62 -735.085 44.831.583
2022-05-04 2022-05-02 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -13.942 471.607 -2,87 95,38 -1.329.788 44.981.876
2022-04-22 2022-04-22 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -25.000 817.565 -2,97
2022-04-22 2022-04-22 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -1.087 485.549 -0,22 109,39 -118.907 53.114.205
2022-04-22 2022-04-22 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -1.800 486.636 -0,37 107,94 -194.292 52.527.490
2022-04-22 2022-04-22 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -5.700 488.436 -1,15 107,02 -610.014 52.272.421
2022-04-22 2022-04-22 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -16.413 494.136 -3,21 106,10 -1.741.419 52.427.830
2022-04-22 2022-04-22 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 25.000 510.549 5,15 22,14 553.500 11.303.555
2022-04-08 2022-04-08 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -25.000 842.565 -2,88
2022-04-08 2022-04-08 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -16.687 485.549 -3,32 112,72 -1.880.959 54.731.083
2022-04-08 2022-04-08 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -8.313 502.236 -1,63 111,70 -928.562 56.099.761
2022-04-08 2022-04-08 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 25.000 510.549 5,15 22,14 553.500 11.303.555
2022-04-01 2022-03-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -35.480 485.549 -6,81 105,52 -3.743.850 51.235.130
2022-04-01 2022-03-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -14.520 521.029 -2,71 104,61 -1.518.937 54.504.844
2022-03-25 2022-03-25 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -25.000 867.565 -2,80
2022-03-25 2022-03-25 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -25.000 535.549 -4,46 109,37 -2.734.340 58.574.922
2022-03-25 2022-03-25 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 25.000 560.549 4,67 22,14 553.500 12.410.555
2022-03-11 2022-03-11 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -25.000 892.565 -2,72
2022-03-11 2022-03-11 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -6.662 535.549 -1,23 101,38 -675.394 54.293.958
2022-03-11 2022-03-11 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -18.338 542.211 -3,27 100,77 -1.847.920 54.638.602
2022-03-11 2022-03-11 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 25.000 560.549 4,67 22,14 553.500 12.410.555
2022-03-01 2022-02-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -1.208 535.549 -0,23 93,57 -113.033 50.111.320
2022-03-01 2022-02-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -2.900 536.757 -0,54 92,50 -268.250 49.650.022
2022-03-01 2022-02-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -19.000 539.657 -3,40 91,54 -1.739.260 49.400.202
2022-03-01 2022-02-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -26.892 558.657 -4,59 90,41 -2.431.306 50.508.179
2022-03-01 2022-02-25 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -25.000 917.565 -2,65
2022-03-01 2022-02-25 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -25.000 585.549 -4,09 92,51 -2.312.662 54.167.089
2022-03-01 2022-02-25 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 25.000 610.549 4,27 22,14 553.500 13.517.555
2022-02-11 2022-02-11 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -25.000 942.565 -2,58
2022-02-11 2022-02-11 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -5.337 585.549 -0,90 97,74 -521.638 57.231.559
2022-02-11 2022-02-11 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -19.663 590.886 -3,22 97,32 -1.913.603 57.505.026
2022-02-11 2022-02-11 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 25.000 610.549 4,27 22,14 553.500 13.517.555
2022-02-02 2022-02-01 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
M - Exercise -9.087 0 -100,00
2022-02-02 2022-02-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -3.767 40.923 -8,43 94,33 -355.341 3.860.267
2022-02-02 2022-02-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 9.087 44.690 25,52
2022-01-31 2022-01-31 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -11.206 585.549 -1,88 92,42 -1.035.659 54.116.439
2022-01-31 2022-01-31 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -74.253 596.755 -11,07 91,94 -6.826.821 54.865.655
2022-01-31 2022-01-31 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -14.541 671.008 -2,12 90,95 -1.322.504 61.028.178
2022-01-31 2022-01-28 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -25.000 967.565 -2,52
2022-01-31 2022-01-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -25.000 685.549 -3,52 90,00 -2.250.000 61.699.410
2022-01-31 2022-01-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 25.000 710.549 3,65 22,14 553.500 15.731.555
2022-01-24 2022-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
M - Exercise -20.336 0 -100,00
2022-01-24 2022-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -9.009 685.549 -1,30 86,42 -778.558 59.245.145
2022-01-24 2022-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 20.336 694.558 3,02
2022-01-14 2022-01-14 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -25.000 992.565 -2,46
2022-01-14 2022-01-14 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -25.000 674.222 -3,58 90,02 -2.250.412 60.691.105
2022-01-14 2022-01-14 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 25.000 699.222 3,71 22,14 553.500 15.480.775
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -4.657 9.314 -33,33
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -3.386 3.387 -49,99
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -34.928 69.857 -33,33
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -46.466 23.200 -66,70
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -44.266 44.270 -50,00
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -58.055 58.055 -50,00
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -58.035 0 -100,00
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -3.636 35.603 -9,27 101,84 -370.290 3.625.810
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 8.043 39.239 25,78
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -174.906 674.222 -20,60 101,84 -17.812.427 68.662.768
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 152.896 849.128 21,96
2022-01-06 2022-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 241.750 696.232 53,19
2022-01-06 2022-01-04 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
A - Award 21.424 21.424
2022-01-06 2022-01-04 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
A - Award 73.796 73.796
2022-01-04 2021-12-31 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -25.000 1.017.565 -2,40
2022-01-04 2021-12-31 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -7.522 454.482 -1,63 108,55 -816.513 49.334.021
2022-01-04 2021-12-31 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -67.478 462.004 -12,74 108,02 -7.288.974 49.905.672
2022-01-04 2021-12-31 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 25.000 529.482 4,96 22,14 553.500 11.722.731
2021-12-01 2021-11-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -13.487 504.482 -2,60 103,54 -1.396.444 52.234.066
2021-12-01 2021-11-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -15.875 517.969 -2,97 102,62 -1.629.092 53.153.979
2021-12-01 2021-11-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -20.638 533.844 -3,72 101,48 -2.094.344 54.174.489
2021-11-03 2021-11-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -637 554.482 -0,11 120,09 -76.497 66.587.743
2021-11-03 2021-11-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -9.733 555.119 -1,72 119,36 -1.161.731 66.259.004
2021-11-03 2021-11-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -6.829 564.852 -1,19 118,46 -808.963 66.912.368
2021-11-03 2021-11-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -7.801 571.681 -1,35 117,31 -915.135 67.063.898
2021-11-03 2021-10-26 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 100.300 100.300
2021-11-03 2021-10-26 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -100.300 31.196 -76,28
2021-10-01 2021-09-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -600 579.482 -0,10 112,01 -67.206 64.907.779
2021-10-01 2021-09-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -18.940 580.082 -3,16 110,80 -2.098.552 64.273.086
2021-10-01 2021-09-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -30.460 599.022 -4,84 109,96 -3.349.382 65.868.459
2021-10-01 2021-09-17 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 110.502 131.496 526,35
2021-10-01 2021-09-17 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -110.502 629.482 -14,93
2021-10-01 2021-09-17 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift 107.739 107.739
2021-10-01 2021-09-17 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -107.739 739.984 -12,71
2021-08-27 2021-08-27 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -7.435 1.042.565 -0,71
2021-08-27 2021-08-27 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 7.435 847.723 0,88 22,14 164.611 18.768.587
2021-07-30 2021-07-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -2.434 840.288 -0,29 102,57 -249.655 86.188.340
2021-07-30 2021-07-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -22.566 842.722 -2,61 101,65 -2.293.834 85.662.691
2021-07-30 2021-07-28 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 69.668 69.668
2021-07-30 2021-07-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -15.432 865.288 -1,75 102,50 -1.581.780 88.692.020
2021-07-30 2021-07-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 34.833 880.720 4,12
2021-07-30 2021-07-08 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -5.000 845.887 -0,59
2021-07-02 2021-06-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -1.408 850.887 -0,17 94,78 -133.450 80.647.070
2021-07-02 2021-06-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -23.592 852.295 -2,69 93,80 -2.212.930 79.945.271
2021-06-16 2021-06-14 4 AUPH Aurinia Pharmaceuticals Inc.
Stock Option (right to buy)
A - Award 31.347 31.347
2021-06-04 2021-06-02 4 XCUR EXICURE, INC.
Stock Option (right to buy)
A - Award 50.000 50.000
2021-06-03 2021-06-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -17.524 875.887 -1,96 92,21 -1.615.888 80.765.540
2021-06-03 2021-06-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -7.476 893.411 -0,83 91,00 -680.316 81.300.401
2021-04-30 2021-04-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -20.872 899.838 -2,27 95,14 -1.985.762 85.610.587
2021-04-30 2021-04-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -4.128 920.710 -0,45 94,15 -388.651 86.684.846
2021-03-03 2021-03-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -2.312 924.838 -0,25 91,98 -212.649 85.063.177
2021-03-03 2021-03-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -24.663 927.150 -2,59 91,29 -2.251.488 84.639.616
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 69.666 69.666
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 18.868 18.868
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -4.179 951.813 -0,44 87,17 -364.283 82.969.539
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 9.433 955.992 1,00
2021-02-03 2021-02-01 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
M - Exercise -9.087 9.087 -50,00
2021-02-03 2021-02-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -2.950 19.945 -12,88 77,04 -227.268 1.536.563
2021-02-03 2021-02-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 9.087 22.895 65,81
2021-01-22 2021-01-22 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -3.871 946.559 -0,41 76,90 -297.692 72.793.416
2021-01-22 2021-01-22 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -7.452 950.430 -0,78 76,25 -568.225 72.471.523
2021-01-22 2021-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
M - Exercise -2.575 0 -100,00
2021-01-22 2021-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
M - Exercise -20.330 20.336 -49,99
2021-01-22 2021-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -755 13.808 -5,18 77,43 -58.460 1.069.153
2021-01-22 2021-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 2.575 14.563 21,48
2021-01-22 2021-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -9.007 957.882 -0,93 77,43 -697.412 74.168.803
2021-01-22 2021-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 20.330 966.889 2,15
2021-01-15 2021-01-15 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -2.299 946.559 -0,24 79,10 -181.851 74.872.817
2021-01-15 2021-01-15 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -127.504 948.858 -11,85 78,26 -9.978.756 74.259.809
2021-01-15 2021-01-15 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -81.401 1.076.362 -7,03 77,26 -6.289.285 83.162.957
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -3.386 6.773 -33,33
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -58.055 116.110 -33,33
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -152.967 0 -100,00
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -58.035 58.035 -50,00
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -1.597 11.988 -11,76 73,28 -117.028 878.481
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 3.386 13.585 33,20
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -337.380 1.157.763 -22,57 73,28 -24.723.206 84.840.873
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 492.294 1.495.143 49,09
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 269.057 1.002.849 36,67
2021-01-06 2021-01-04 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
A - Award 13.971 13.971
2021-01-06 2021-01-04 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
A - Award 104.785 104.785
2020-08-07 2020-08-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -1.300 733.792 -0,18 75,75 -98.470 55.582.029
2020-08-07 2020-08-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -22.120 735.092 -2,92 75,19 -1.663.123 55.268.921
2020-08-07 2020-08-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -14.718 757.212 -1,91 73,86 -1.087.139 55.931.161
2020-08-07 2020-08-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -18.263 771.930 -2,31 72,75 -1.328.721 56.161.613
2020-08-07 2020-08-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -11.262 790.193 -1,41 71,57 -805.991 56.551.979
2020-08-07 2020-08-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -42.337 801.455 -5,02 70,76 -2.995.969 56.714.803
2020-08-07 2020-05-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
G - Gift -5.000 843.792 -0,59
2020-06-08 2020-06-04 4 XCUR EXICURE, INC.
Stock Option (right to buy)
A - Award 21.693 21.693
2020-05-22 2020-05-20 4 ASRT Assertio Holdings, Inc.
Common Stock
A - Award 211.111 211.111
2020-05-22 2020-05-20 4 ASRT Assertio Holdings, Inc.
Common Stock
A - Award 49.143 49.143
2020-05-21 2020-05-20 4 ZCOR Zyla Life Sciences
Common Stock
D - Sale to Issuer -26.953 0 -100,00
2020-04-24 2020-04-23 4 ZCOR Zyla Life Sciences
Restricted Stock Units
M - Exercise 6.667 13.333 100,02
2020-04-24 2020-04-23 4 ZCOR Zyla Life Sciences
Common Stock
F - Taxes -952 5.715 -14,28 1,75 -1.666 10.001
2020-04-24 2020-04-23 4 ZCOR Zyla Life Sciences
Common Stock
M - Exercise 6.667 6.667 1,75 11.667 11.667
2020-03-05 2020-03-04 4 ZCOR Zyla Life Sciences
Common Stock
A - Award 13.620 13.620
2020-02-21 2020-02-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -93.864 847.743 -9,97 35,23 -3.306.829 29.865.986
2020-02-21 2020-02-19 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 96.864 96.864
2020-02-21 2020-02-19 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -21.457 941.607 -2,23 36,06 -773.739 33.954.348
2020-02-21 2020-02-19 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 48.432 963.064 5,30
2020-02-04 2020-02-01 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSUs)
M - Exercise -9.086 18.174 -33,33
2020-02-04 2020-02-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -2.668 9.150 -22,58 34,49 -92.019 315.584
2020-02-04 2020-02-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 9.086 11.818 332,58
2020-01-23 2020-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 2.575 2.575
2020-01-23 2020-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 40.666 40.666
2020-01-23 2020-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -891 2.732 -24,59 38,25 -34.081 104.499
2020-01-23 2020-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 2.574 3.623 245,38
2020-01-23 2020-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -9.006 914.632 -0,98 38,25 -344.480 34.984.674
2020-01-23 2020-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 20.329 923.638 2,25
2020-01-07 2020-01-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -84.886 903.309 -8,59 35,57 -3.019.395 32.130.701
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -152.966 152.967 -50,00
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -58.034 116.070 -33,33
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -168.319 988.195 -14,55 36,10 -6.076.316 35.673.840
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 168.523 1.156.514 17,06
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 211.000 987.991 27,16
2020-01-07 2020-01-03 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
A - Award 10.159 10.159
2020-01-07 2020-01-03 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
A - Award 174.165 174.165
2019-10-17 2019-10-15 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -204.682 0 -100,00
2019-10-17 2019-10-15 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -107.187 0 -100,00
2019-10-17 2019-10-15 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -320.174 776.991 -29,18 28,02 -8.970.283 21.768.879
2019-10-17 2019-10-15 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 204.682 1.097.165 22,93 7,61 1.557.630 8.349.426
2019-10-17 2019-10-15 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 107.187 892.483 13,65 2,40 257.249 2.141.959
2019-09-04 2019-08-30 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -2.500 785.296 -0,32 28,00 -70.000 21.988.288
2019-08-23 2019-08-22 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -1.984 787.796 -0,25 28,00 -55.552 22.058.288
2019-08-23 2019-08-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -11.000 789.780 -1,37 28,01 -308.110 22.121.738
2019-08-23 2019-08-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -45.836 800.780 -5,41 28,00 -1.283.408 22.421.840
2019-07-22 2019-07-22 4 XCUR EXICURE, INC.
Stock Option (right to buy)
A - Award 43.386 43.386
2019-04-24 2019-04-23 4 ZCOR Egalet Corp
Common Stock
A - Award 20.000 20.000
2019-03-25 2019-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -125.000 0 -100,00
2019-03-25 2019-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -55.375 844.246 -6,16 26,84 -1.486.265 22.659.563
2019-03-25 2019-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 125.000 899.621 16,14
2019-02-22 2019-02-20 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -74.657 774.621 -8,79 21,54 -1.608.112 16.685.336
2019-02-22 2019-02-20 4 HZNP Horizon Pharma plc
Ordinary Shares
A - Award 168.521 849.278 24,75
2019-02-04 2019-01-31 4 EGLT Egalet Corp
Stock Option (Right to Buy)
D - Sale to Issuer -75.000 0 -100,00
2019-02-04 2019-01-31 4 EGLT Egalet Corp
Stock Option (Right to Buy)
D - Sale to Issuer -58.133 0 -100,00
2019-02-04 2019-01-31 4 EGLT Egalet Corp
Stock Option (Right to Buy)
D - Sale to Issuer -29.666 0 -100,00
2019-02-04 2019-01-31 4 EGLT Egalet Corp
Stock Option (Right to Buy)
D - Sale to Issuer -10.000 0 -100,00
2019-02-04 2019-01-31 4 EGLT Egalet Corp
Stock Option (Right to Buy)
D - Sale to Issuer -20.000 0 -100,00
2019-02-04 2019-01-31 4 EGLT Egalet Corp
Stock Option (Right to Buy)
D - Sale to Issuer -667 0 -100,00
2019-02-04 2019-01-31 4 EGLT Egalet Corp
Stock Option (Right to Buy)
D - Sale to Issuer -1.328 0 -100,00
2019-02-04 2019-01-31 4 EGLT Egalet Corp
Common Stock
D - Sale to Issuer -150 0 -100,00
2019-02-01 2019-02-01 4 HZNP Horizon Pharma plc
Restricted Stock Units (RSU)
A - Award 27.260 27.260
2019-01-08 2019-01-05 4 HZNP Horizon Pharma plc
Restricted Stock Units (RSU)
M - Exercise -152.966 305.933 -33,33
2019-01-08 2019-01-05 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -68.080 680.757 -9,09 20,39 -1.388.151 13.880.635
2019-01-08 2019-01-05 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 152.966 748.837 25,67
2019-01-08 2019-01-04 4 HZNP Horizon Pharma plc
Restricted Stock Units (RSU)
A - Award 174.104 174.104
2018-11-21 2018-11-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
M - Exercise -18.318 204.682 -8,21
2018-11-21 2018-11-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
M - Exercise -31.483 107.187 -22,70
2018-11-21 2018-11-19 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 18.318 595.871 3,17 7,61 139.400 4.534.578
2018-11-21 2018-11-19 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 31.483 577.553 5,77 2,40 75.559 1.386.127
2018-11-16 2018-11-14 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
M - Exercise -196.794 0 -100,00
2018-11-16 2018-11-14 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
M - Exercise -107.219 0 -100,00
2018-11-16 2018-11-14 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
M - Exercise -104.334 0 -100,00
2018-11-16 2018-11-14 4 HZNP Horizon Pharma plc
Ordinary Shares
S - Sale X -408.347 546.070 -42,78 21,54 -8.795.794 11.762.348
2018-11-16 2018-11-14 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 196.794 954.417 25,98 4,96 976.098 4.733.908
2018-11-16 2018-11-14 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 107.219 757.623 16,48 12,94 1.387.414 9.803.642
2018-11-16 2018-11-14 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 104.334 650.404 19,11 5,20 542.537 3.382.101
2018-06-05 2018-06-01 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
M - Exercise -83.353 0 -100,00
2018-06-05 2018-06-01 4 HZNP Horizon Pharma plc
Ordinary Shares
S - Sale X -83.353 546.070 -13,24 16,17 -1.348.218 8.832.573
2018-06-05 2018-06-01 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 83.353 629.423 15,26 10,43 869.372 6.564.882
2018-05-15 2018-05-14 4 EGLT Egalet Corp
Stock Option (Right to Buy)
A - Award 75.000 75.000
2018-05-07 2018-05-03 4 HZNP Horizon Pharma plc
Restricted Stock Units (RSU)
A - Award 458.899 458.899
2018-03-27 2018-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -125.000 125.000 -50,00
2018-03-27 2018-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -55.375 543.700 -9,24 13,86 -767.498 7.535.682
2018-03-27 2018-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 125.000 599.075 26,37
2018-02-13 2018-02-13 4 SCMP Sucampo Pharmaceuticals, Inc.
Director Stock Option (right to buy)
D - Sale to Issuer -10.000 0 -100,00 7,70 -77.000
2018-02-13 2018-02-13 4 SCMP Sucampo Pharmaceuticals, Inc.
Common Stock, Class A
D - Sale to Issuer -5.130 0 -100,00 18,00 -92.340
2018-01-03 2018-01-02 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -49.500 0 -100,00
2018-01-03 2018-01-02 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -23.626 474.075 -4,75 15,02 -354.863 7.120.606
2018-01-03 2018-01-02 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 49.500 497.701 11,04
2017-06-12 2017-06-08 4 EGLT Egalet Corp
Stock Option (Right to Buy)
A - Award 58.133 58.133
2017-06-05 2017-06-01 4 SCMP Sucampo Pharmaceuticals, Inc.
Director Stock Option (right to buy)
A - Award 10.000 40.000 33,33
2017-06-05 2017-06-01 4 SCMP Sucampo Pharmaceuticals, Inc.
Common Stock
A - Award 5.130 14.930 52,35
2017-05-22 2017-02-10 4 XOMA XOMA Corp
Non-Qualified Share Option (right to buy)
A - Award 8.000 8.000
2017-03-24 2017-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -125.000 250.000 -33,33
2017-03-24 2017-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -57.125 446.721 -11,34 14,56 -831.740 6.504.258
2017-03-24 2017-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 125.000 503.846 32,99
2017-01-04 2017-01-02 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -49.500 49.500 -50,00
2017-01-04 2017-01-02 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -32.175 0 -100,00
2017-01-04 2017-01-02 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -37.703 378.846 -9,05 16,18 -610.035 6.129.728
2017-01-04 2017-01-02 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 81.675 416.549 24,39
2016-08-19 2016-08-18 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
M - Exercise -8.330 138.670 -5,67
2016-08-19 2016-08-18 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 8.330 334.874 2,55 2,40 19.992 803.698
2016-08-02 2016-07-21 4 XOMA XOMA Corp
Non-Qualified Share Option (right to buy)
A - Award 60.532 60.532
2016-08-02 2016-07-21 4 XOMA XOMA Corp
Common Shares
A - Award 48.246 129.314 59,51
2016-06-17 2016-06-15 4 EGLT Egalet Corp
Stock Option (Right to Buy)
A - Award 29.666 29.666 4,98 147.737 147.737
2016-06-17 2015-06-10 4 EGLT Egalet Corp
Common Stock (Right to Buy)
A - Award 10.000 10.000 12,08 120.800 120.800
2016-06-06 2016-06-02 4 SCMP Sucampo Pharmaceuticals, Inc.
Common Stock
A - Award 9.800 9.800
2016-05-31 2016-05-28 4 XOMA XOMA Corp
Restricted Stock Units
M - Exercise -2.800 0 -100,00
2016-05-31 2016-05-28 4 XOMA XOMA Corp
Common Shares
M - Exercise 2.800 81.068 3,58
2016-03-24 2016-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -125.000 375.000 -25,00
2016-03-24 2016-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -57.125 324.493 -14,97 16,32 -932.280 5.295.726
2016-03-24 2016-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 125.000 381.618 48,71
2016-01-05 2016-01-02 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -49.500 99.000 -33,33
2016-01-05 2016-01-02 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -32.175 32.175 -50,00
2016-01-05 2016-01-02 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -30.845 256.618 -10,73 21,67 -668.411 5.560.912
2016-01-05 2016-01-02 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 81.675 287.463 39,69
2015-12-14 2015-12-11 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
M - Exercise -2.082 196.794 -1,05
2015-12-14 2015-12-11 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 2.082 205.788 1,02 4,96 10.327 1.020.708
2015-12-10 2015-12-08 4/A HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -33.211 0 -100,00
2015-12-10 2015-12-08 4/A HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -15.178 203.706 -6,93 20,40 -309.631 4.155.602
2015-12-10 2015-12-08 4/A HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 33.211 218.884 17,89
2015-12-09 2015-12-08 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -33.211 0 -100,00
2015-12-09 2015-12-08 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -15.178 203.706 -6,93 21,40 -324.809 4.359.308
2015-12-09 2015-12-08 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 33.211 218.884 17,89
2015-10-14 2015-10-12 4 SCMP Sucampo Pharmaceuticals, Inc.
Director Stock Option (right to buy)
A - Award 30.000 30.000
2015-06-01 2015-05-28 4 XOMA XOMA Corp
Restricted Stock Units
M - Exercise -2.800 0 -100,00
2015-06-01 2015-05-28 4 XOMA XOMA Corp
Restricted Stock Units
M - Exercise -2.800 0 -100,00
2015-06-01 2015-05-28 4 XOMA XOMA Corp
Common Shares
M - Exercise 2.800 78.268 3,71
2015-06-01 2015-05-28 4 XOMA XOMA Corp
Common Shares
M - Exercise 2.800 78.268 3,71
2015-05-22 2015-05-21 4 XOMA XOMA Corp
Non-Qualified Share Option (right to buy)
A - Award 36.873 36.873 3,39 124.999 124.999
2015-05-22 2015-05-21 4 XOMA XOMA Corp
Common Shares
A - Award 36.873 72.668 103,01
2015-05-08 2015-05-06 4 HZNP Horizon Pharma plc
Performance Share Units (PSU)
A - Award 2.025.000 2.025.000
2015-05-08 2015-05-06 4 HZNP Horizon Pharma plc
Performance Share Units (PSU)
A - Award 45.000 675.000 7,14
2015-05-08 2015-05-06 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 1.650.000 1.650.000
2015-05-05 2015-05-01 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
M - Exercise -18.079 198.876 -8,33
2015-05-05 2015-05-01 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
M - Exercise -24.603 104.334 -19,08
2015-05-05 2015-05-01 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
M - Exercise -38.348 83.353 -31,51
2015-05-05 2015-05-01 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
M - Exercise -5.568 107.219 -4,94
2015-05-05 2015-05-01 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 18.079 175.125 11,51 4,96 89.672 868.620
2015-05-05 2015-05-01 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 24.603 157.046 18,58 5,20 127.936 816.639
2015-05-05 2015-05-01 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 38.348 132.443 40,75 10,43 399.970 1.381.380
2015-05-05 2015-05-01 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 5.568 94.095 6,29 12,94 72.050 1.217.589
2015-03-25 2015-03-23 4 HZNP Horizon Pharma plc
Performance Share Units (PSU)
A - Award 630.000 630.000
2015-03-25 2015-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 500.000 500.000
2015-03-25 2015-03-23 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 1.050.000 1.050.000
2015-01-26 2014-12-08 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -33.210 33.211 -50,00
2015-01-26 2014-12-08 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -14.065 33.205 -29,75 12,99 -182.704 431.333
2015-01-26 2014-12-08 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 33.210 47.270 236,20
2015-01-26 2014-01-02 4/A HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -32.175 96.525 -25,00
2015-01-26 2014-01-02 4/A HZNP Horizon Pharma plc
Common Stock
M - Exercise 32.175 180.672 21,67
2015-01-06 2015-01-02 4 HZNP Horizon Pharma plc
Restricted stock units
M - Exercise -49.500 148.500 -25,00
2015-01-06 2015-01-02 4 HZNP Horizon Pharma plc
Restricted stock units
M - Exercise -32.175 64.350 -33,33
2015-01-06 2015-01-02 4 HZNP Horizon Pharma plc
Ordinary shares
F - Taxes -26.353 88.527 -22,94 12,80 -337.318 1.133.146
2015-01-06 2015-01-02 4 HZNP Horizon Pharma plc
Ordinary shares
M - Exercise 81.675 114.880 245,97
2014-11-20 2014-11-19 4 HZNP Horizon Pharma plc
Ordinary Shares
S - Sale -150.000 14.060 -91,43 12,05 -1.807.500 169.423
2014-11-17 2014-11-13 4 XOMA XOMA Corp
Restricted Stock Units
M - Exercise -4.498 0 -100,00
2014-11-17 2014-11-13 4 XOMA XOMA Corp
Common Shares
M - Exercise 4.498 35.795 14,37
2014-10-01 2014-09-30 4 EGLT Egalet Corp
Stock Option (Right to Buy)
A - Award 20.000 20.000
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
D - Sale to Issuer -198.000 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
D - Sale to Issuer -223.000 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
D - Sale to Issuer -96.525 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
D - Sale to Issuer -147.000 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
D - Sale to Issuer -66.421 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
D - Sale to Issuer -216.955 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
D - Sale to Issuer -112.787 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
D - Sale to Issuer -128.937 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
D - Sale to Issuer -121.701 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Common Stock
D - Sale to Issuer -164.060 0 -100,00
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 198.000 198.000
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 223.000 223.000
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 96.525 96.525
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 147.000 147.000
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Restricted Stock Units
A - Award 66.421 66.421
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 216.955 216.955
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 112.787 112.787
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 128.937 128.937
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
A - Award 121.701 121.701
2014-09-22 2014-09-19 4 HZNP Horizon Pharma plc
Ordinary Shares
A - Award 164.060 164.060
2014-09-16 2014-09-12 4 XOMA XOMA Corp
Non-Qualified Share Option (right to buy)
A - Award 7.000 7.000 4,73 33.110 33.110
2014-09-16 2014-09-12 4 XOMA XOMA Corp
Common Shares
A - Award 5.500 31.297 21,32
2014-06-11 2014-06-09 4 EGLT Egalet Corp
Stock Option (Right to Buy)
A - Award 667 667
2014-05-29 2014-05-28 4 XOMA XOMA Corp
Restricted Stock Units
M - Exercise -2.800 2.800 -50,00
2014-05-29 2014-05-28 4 XOMA XOMA Corp
Restricted Stock Units
M - Exercise -2.800 2.800 -50,00
2014-05-29 2014-05-28 4 XOMA XOMA Corp
Common Shares
M - Exercise 2.800 25.797 12,18
2014-05-29 2014-05-28 4 XOMA XOMA Corp
Common Shares
M - Exercise 2.800 25.797 12,18
2014-05-27 2014-05-22 4 XOMA XOMA Corp
Non-Qualified Share Option (right to buy)
A - Award 11.600 11.600 3,87 44.892 44.892
2014-05-27 2014-05-22 4 XOMA XOMA Corp
Common Shares
A - Award 8.400 20.197 71,20
2014-05-21 2014-05-19 4 HZNP HORIZON PHARMA, INC.
Common stock
S - Sale X -31.742 148.930 -17,57 12,94 -410.741 1.927.154
2014-03-17 2014-03-13 4 RPTP Raptor Pharmaceutical Corp
Stock options (right to buy)
M - Exercise X -5.521 52.918 -9,45
2014-03-17 2014-03-13 4 RPTP Raptor Pharmaceutical Corp
Common Stock
S - Sale X -5.521 0 -100,00 15,22 -84.018
2014-03-17 2014-03-13 4 RPTP Raptor Pharmaceutical Corp
Common Stock
M - Exercise X 5.521 5.521 3,33 18.385 18.385
2014-02-11 2014-02-07 4 RPTP Raptor Pharmaceutical Corp
Stock options (right to buy)
A - Award -50.000 50.000 -50,00
2014-01-15 2014-01-13 4 RPTP Raptor Pharmaceutical Corp
Stock options (right to buy)
M - Exercise X -5.520 58.439 -8,63
2014-01-15 2014-01-13 4 RPTP Raptor Pharmaceutical Corp
Common Stock
S - Sale X -5.520 0 -100,00 15,06 -83.113
2014-01-15 2014-01-13 4 RPTP Raptor Pharmaceutical Corp
Common Stock
M - Exercise X 5.520 5.520 3,33 18.382 18.382
2014-01-10 2014-01-02 4 HZNP HORIZON PHARMA, INC.
Restricted stock units
A - Award 198.000 198.000
2014-01-10 2014-01-02 4 HZNP HORIZON PHARMA, INC.
Employee stock options (right to buy)
A - Award 223.000 223.000
2013-12-09 2013-12-09 4 HZNP HORIZON PHARMA, INC.
Restricted stock units
M - Exercise -33.210 66.421 -33,33
2013-12-09 2013-12-09 4 HZNP HORIZON PHARMA, INC.
Common Stock
S - Sale -12.124 148.497 -7,55 6,79 -82.322 1.008.295
2013-12-09 2013-12-09 4 HZNP HORIZON PHARMA, INC.
Common Stock
M - Exercise 33.210 160.621 26,07
2013-12-09 2013-12-05 4 HZNP HORIZON PHARMA, INC.
Common Stock
A - Award 43.290 127.411 51,46
2013-11-15 2013-11-13 4 XOMA XOMA Corp
Restricted Stock Units
M - Exercise -4.498 1.102 -80,32
2013-11-15 2013-11-13 4 XOMA XOMA Corp
Common Shares
M - Exercise 4.498 11.797 61,62
2013-11-15 2013-11-13 4 RPTP Raptor Pharmaceutical Corp
Stock options (right to buy)
M - Exercise X -5.521 63.959 -7,95
2013-11-15 2013-11-13 4 RPTP Raptor Pharmaceutical Corp
Common Stock
S - Sale X -5.521 0 -100,00 12,44 -68.655
2013-11-15 2013-11-13 4 RPTP Raptor Pharmaceutical Corp
Common Stock
M - Exercise X 5.521 5.521 3,33 18.385 18.385
2013-09-17 2013-09-13 4 RPTP Raptor Pharmaceutical Corp
Stock options (right to buy)
M - Exercise X -5.520 69.480 -7,36
2013-09-17 2013-09-13 4 RPTP Raptor Pharmaceutical Corp
Common Stock
S - Sale X -5.520 0 -100,00 14,07 -77.668
2013-09-17 2013-09-13 4 RPTP Raptor Pharmaceutical Corp
Common Stock
M - Exercise X 5.520 5.520 3,33 18.382 18.382
2013-05-29 2013-05-28 4 XOMA XOMA Corp
Restricted Stock Units
M - Exercise -2.800 5.600 -33,33
2013-05-29 2013-05-28 4 XOMA XOMA Corp
Common Shares
M - Exercise 2.800 7.299 62,24
2013-05-24 2013-05-23 4 XOMA XOMA Corp
Restricted Stock Units
A - Award 8.400 8.400
2013-05-24 2013-05-23 4 XOMA XOMA Corp
Non-Qualified Share Option (right to buy)
A - Award 11.600 11.600 4,13 47.908 47.908
2013-01-03 2013-01-02 4 HZNP HORIZON PHARMA, INC.
Restricted stock units
A - Award 128.700 128.700
2013-01-03 2013-01-02 4 HZNP HORIZON PHARMA, INC.
Employee stock options (right to buy)
A - Award 147.000 147.000
2013-01-03 2013-01-02 4 HZNP HORIZON PHARMA, INC.
Common stock
S - Sale X -20.749 78.661 -20,87 2,36 -48.968 185.640
2012-12-12 2012-12-10 4 HZNP HORIZON PHARMA, INC.
Restricted stock units
M - Exercise -33.211 99.631 -25,00
2012-12-12 2012-12-10 4 HZNP HORIZON PHARMA, INC.
Common Stock
S - Sale -10.301 99.410 -9,39 2,28 -23.486 226.655
2012-12-12 2012-12-10 4 HZNP HORIZON PHARMA, INC.
Common Stock
M - Exercise 33.211 109.711 43,41
2012-11-15 2012-11-13 4 XOMA XOMA Corp
Restricted Stock Units
M - Exercise -4.499 8.996 -33,34
2012-11-15 2012-11-13 4 XOMA XOMA Corp
Common Shares
M - Exercise 4.499 4.499
2012-09-28 2012-09-25 4 RPTP Raptor Pharmaceutical Corp
Stock options (right to buy)
A - Award 50.000 230.000 27,78
2012-07-27 2012-07-26 4 HZNP HORIZON PHARMA, INC.
Common Stock
A - Award 42.000 70.000 150,00
2012-05-25 2012-05-24 4 XOMA XOMA Corp
Restricted Stock Units
A - Award 8.400 8.400
2012-05-25 2012-05-24 4 XOMA XOMA Corp
Non-Qualified Share Option (right to buy)
A - Award 11.600 11.600 2,36 27.376 27.376
2012-03-07 2012-03-02 4 HZNP HORIZON PHARMA, INC.
Common Stock
A - Award 28.000 28.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)